Is Adalimumab-adaz Injection (Hyrimoz) in shortage?
Adalimumab-adaz Injection is listed by FDA as being discontinued by at least one maker (updated Jan 13, 2026).
Every listed package
FDA tracks shortages per package. What each maker reports, most recently updated first:
- Hyrimoz, Injection, 80 mg/.8 mL (NDC 61314-454-36)
Equivalent Sandoz format is available.
Maker contact: 800-525-8747
- Hyrimoz, Injection, 80 mg/.8 mL (NDC 61314-454-68)
Equivalent Sandoz format is available.
Maker contact: 800-525-8747
- Hyrimoz, Injection, 40 mg/.4 mL (NDC 61314-473-64)
Equivalent Sandoz format is available.
Maker contact: 800-525-8747
- Hyrimoz, Injection, Kit (NDC 61314-517-36)
Equivalent Sandoz format is available.
Maker contact: 800-525-8747
- Hyrimoz, Injection, Kit (NDC 61314-531-64)
Equivalent Sandoz format is available.
Maker contact: 800-525-8747
Adalimumab-adaz Injection shortage questions
Is Adalimumab-adaz Injection (Hyrimoz) in shortage?
Adalimumab-adaz Injection is listed by FDA as being discontinued by at least one maker (updated Jan 13, 2026).
What should I do if I can’t get Adalimumab-adaz Injection?
Don’t stop or ration it on your own. Ask your pharmacist whether another strength, package size or maker is in stock, and ask your prescriber about an alternative if none is.
Source: FDA Drug Shortages Database via openFDA. FDA notes that openFDA data is unvalidated and should not be used to make decisions about medical care; ask your pharmacist or prescriber before changing any medication. FDA Drug Shortages Database.